The history of cancer pain and bone-targeted agents: 10 most commonly asked questions

The prevalence of pain and skeletal complications of metastatic bone disease is high and an important factor, which contributes to decreased quality of life and low survival rate. Bone-targeted agents are well-established therapies to reduce the skeletal-related events in patients with bone metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Cláudia Margarida Pereira, Fragoso, Maria, Ferreira, Marta, Pereira, Filipa Ferreira, Pereira, Deolinda, Medeiros, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302803/
https://www.ncbi.nlm.nih.gov/pubmed/30588109
http://dx.doi.org/10.2147/CMAR.S174731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302803/
https://www.ncbi.nlm.nih.gov/pubmed/30588109
http://dx.doi.org/10.2147/CMAR.S174731

Ejemplares similares